Phospho-Akt1 (Ser129) Antibody [K23C4]

Catalogusnr. F4918

Afdrukken

Biologische Beschrijving

Specificiteit Phospho-Akt1 (Ser129) Antibody [K23C4] detecteert endogene niveaus van totaal Akt1-eiwit alleen wanneer het is gefosforyleerd op Ser129.
Achtergrond Phospho-Akt1 (Ser129) is een specifieke post-translationele modificatie van Akt1 (RAC-alfa serine/threonine-proteïnekinase, PKBα), die plaatsvindt binnen de flexibele linkerregio tussen het pleckstrin homologie (PH) domein en het kinase domein van dit 480-aminozuur-eiwit. Akt1 omvat een N-terminaal PH-domein voor PIP3-gemedieerde membraanrecrutering, een katalytisch kinase domein met belangrijke regulatoire fosforyleringssites op Thr308 (activeringslus) en Ser473 (hydrofoob motief), en een C-terminale regulatoire staart. Fosforylering van Ser129 door proteïnekinase CK2 genereert een consensus S-x-x-D/E-motief dat daaropvolgende modificatie op Ser126 primet en de algehele conformatie van Akt1 stabiliseert. Deze modificatie hyperactiveert Akt1 verder dan de effecten van canonieke PDK1/mTORC2-fosforylering door de associatie met het HSP90 chaperonecomplex te versterken, dat Thr308 beschermt tegen PP2A-gemedieerde defosforylering, waardoor de Akt1-kinaseactiviteit wordt gehandhaafd. Bovendien verbetert phospho-Ser129 de β-catenine/TCF transcriptieactiviteit, hetzij direct, hetzij door Wnt-signaleringscomponenten te stabiliseren, en vergrendelt Akt1 in een uitgebreide actieve conformatie die isoform-specifieke substraatselectie mogelijk maakt, zoals preferentiële fosforylering van palladin, een proces dat niet wordt weerspiegeld in Akt2 vanwege de afwezigheid van de equivalente Ser131-site. Deze modificatie drijft cytoskeletale remodeling, celoverleving door remming van Bad en FoxO, proliferatie door bevordering van cycline D1-stabiliteit en p27/p21-sequestratie, en mTORC1-activering via TSC2-fosforylering, waarbij hiërarchische fosforylering zorgt voor robuuste signaalversterking bij groeifactorstimulatie. Bij ziekte verhogen verhoogde phospho-Ser129-niveaus de overleving en metastase van kankercellen door PI3K/Akt-oncogene signalering te versterken (met name bij borst- en prostaatkanker), dragen bij aan chemoresistentie via aanhoudende HSP90-bescherming, en zijn ze betrokken bij stofwisselingsstoornissen door verstoring van de glucosehomeostase door hyperactivering van Akt1.

Gebruiksinformatie

Toepassing WB Verdunning
WB
1:1000 - 1:10000
Reactiviteit Human
Bron Rabbit Monoclonal Antibody MW 55 kDa
Opslagbuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Opslag
(Vanaf de datum van ontvangst)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referenties

  • https://pubmed.ncbi.nlm.nih.gov/24769357/
  • https://pubmed.ncbi.nlm.nih.gov/15818404/

Toepassingsgegevens

WB

Gevalideerd door Selleck

  • F4918-wb
    Lane 1: MCF-7, Lane 2: MCF-7 (Alkaline Phosphatase treated)